Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...

FILE PHOTO: Jeffrey Smith, Managing Member, CEO and CIO of Starboard Value, speaks during the 13D Monitor's Active-Passive ...

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...

Starboard has built a $1 billion position in Pfizer, but had not previously detailed its concerns about the drugmaker. Smith met with Pfizer CEO Albert Bourla last week, some days after the hedge ...